You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients

Alerts

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address